Immuneering Corp Stock Market Value
| IMRX Stock | USD 2.08 0.02 0.95% |
| Symbol | Immuneering |
Immuneering Corp Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immuneering Corp. If investors know Immuneering will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immuneering Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.97) | Quarterly Revenue Growth (1.00) | Return On Assets (0.37) | Return On Equity (0.62) |
The market value of Immuneering Corp is measured differently than its book value, which is the value of Immuneering that is recorded on the company's balance sheet. Investors also form their own opinion of Immuneering Corp's value that differs from its market value or its book value, called intrinsic value, which is Immuneering Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immuneering Corp's market value can be influenced by many factors that don't directly affect Immuneering Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immuneering Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immuneering Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immuneering Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Immuneering Corp 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Immuneering Corp's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Immuneering Corp.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in Immuneering Corp on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding Immuneering Corp or generate 0.0% return on investment in Immuneering Corp over 30 days. Immuneering Corp is related to or competes with Pmv Pharmaceuticals, Cullinan Oncology, Enliven Therapeutics, Larimar Therapeutics, Centessa Pharmaceuticals, Celcuity LLC, and Ikena Oncology. Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates More
Immuneering Corp Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Immuneering Corp's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Immuneering Corp upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.06 | |||
| Information Ratio | 0.1347 | |||
| Maximum Drawdown | 60.06 | |||
| Value At Risk | (8.68) | |||
| Potential Upside | 15.5 |
Immuneering Corp Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Immuneering Corp's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Immuneering Corp's standard deviation. In reality, there are many statistical measures that can use Immuneering Corp historical prices to predict the future Immuneering Corp's volatility.| Risk Adjusted Performance | 0.1224 | |||
| Jensen Alpha | 1.37 | |||
| Total Risk Alpha | (0.11) | |||
| Sortino Ratio | 0.2268 | |||
| Treynor Ratio | 1.41 |
Immuneering Corp Backtested Returns
Immuneering Corp is very risky given 3 months investment horizon. Immuneering Corp holds Efficiency (Sharpe) Ratio of 0.14, which attests that the entity had a 0.14% return per unit of risk over the last 3 months. We were able to interpolate data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.44% are justified by taking the suggested risk. Use Immuneering Corp Risk Adjusted Performance of 0.1224, downside deviation of 6.06, and Market Risk Adjusted Performance of 1.42 to evaluate company specific risk that cannot be diversified away. Immuneering Corp holds a performance score of 10 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 1.06, which attests to a somewhat significant risk relative to the market. Immuneering Corp returns are very sensitive to returns on the market. As the market goes up or down, Immuneering Corp is expected to follow. Use Immuneering Corp maximum drawdown, as well as the relationship between the skewness and day typical price , to analyze future returns on Immuneering Corp.
Auto-correlation | 0.00 |
No correlation between past and present
Immuneering Corp has no correlation between past and present. Overlapping area represents the amount of predictability between Immuneering Corp time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Immuneering Corp price movement. The serial correlation of 0.0 indicates that just 0.0% of current Immuneering Corp price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | -0.43 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Immuneering Corp lagged returns against current returns
Autocorrelation, which is Immuneering Corp stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Immuneering Corp's stock expected returns. We can calculate the autocorrelation of Immuneering Corp returns to help us make a trade decision. For example, suppose you find that Immuneering Corp has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Immuneering Corp regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Immuneering Corp stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Immuneering Corp stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Immuneering Corp stock over time.
Current vs Lagged Prices |
| Timeline |
Immuneering Corp Lagged Returns
When evaluating Immuneering Corp's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Immuneering Corp stock have on its future price. Immuneering Corp autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Immuneering Corp autocorrelation shows the relationship between Immuneering Corp stock current value and its past values and can show if there is a momentum factor associated with investing in Immuneering Corp.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Immuneering Stock Analysis
When running Immuneering Corp's price analysis, check to measure Immuneering Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immuneering Corp is operating at the current time. Most of Immuneering Corp's value examination focuses on studying past and present price action to predict the probability of Immuneering Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immuneering Corp's price. Additionally, you may evaluate how the addition of Immuneering Corp to your portfolios can decrease your overall portfolio volatility.